硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 Inhibin βA 抗体对
试剂盒

人 Inhibin βA 抗体对

01AB00138

INHBA, or Inhibin Subunit Beta A, is a gene that encodes a member of the transforming growth factor-beta (TGF-β) superfamily of proteins. The INHBA protein plays a key role in regulating follicle-stimulating hormone secretion from the pituitary gland, and is also involved in eye, tooth, and testis development. Elevated expression of INHBA has been associated with various types of cancer, including colorectal cancer, gastric cancer, and head and neck squamous cell carcinoma. Studies have shown that INHBA promotes the proliferation, migration, and invasion of cancer cells, and its overexpression is correlated with poor prognosis and reduced overall survival in cancer patients. The high expression of INHBA in cancer is also linked to increased immune cell infiltration, particularly of macrophages, mast cells, natural killer cells, neutrophils, Th2 cells, and eosinophils. These findings suggest that INHBA plays a critical role in cancer progression and may serve as a potential biomarker and therapeutic target for various types of cancer.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
INHBA
蛋白别名
inhibin subunit beta A; Inhibin beta A
UniProt
P08476
物种
Human

产品详情

靶点名称
Inhibin beta A
蛋白名称
inhibin subunit beta A
蛋白别名
Inhibin beta A chain; Activin beta-A chain; Erythroid differentiation protein; EDF
靶点基因名
INHBA
UniProt
P08476
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

INHBA, or Inhibin Subunit Beta A, is a gene that encodes a member of the transforming growth factor-beta (TGF-β) superfamily of proteins. The INHBA protein plays a key role in regulating follicle-stimulating hormone secretion from the pituitary gland, and is also involved in eye, tooth, and testis development. Elevated expression of INHBA has been associated with various types of cancer, including colorectal cancer, gastric cancer, and head and neck squamous cell carcinoma. Studies have shown that INHBA promotes the proliferation, migration, and invasion of cancer cells, and its overexpression is correlated with poor prognosis and reduced overall survival in cancer patients. The high expression of INHBA in cancer is also linked to increased immune cell infiltration, particularly of macrophages, mast cells, natural killer cells, neutrophils, Th2 cells, and eosinophils. These findings suggest that INHBA plays a critical role in cancer progression and may serve as a potential biomarker and therapeutic target for various types of cancer.